Admission to trading & Total Voting Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN.

Ophir Energy plc

("Ophir" or the "Company")

Admission to trading on the London Stock Exchange & Total Voting Rights

Admission to trading on the London Stock Exchange

London, 13 July 2011: Further to its announcement in July 2011, Ophir is pleased to announce that its ordinary share capital has today been admitted to the premium listing segment of the Official List of the Financial Services Authority and to trading on the London Stock Exchange's main market for listed securities under the ticker "OPHR".

Total Voting Rights

In addition, Ophir today also announces that on commencement of dealing in its ordinary shares, the Company's issued share capital consisted of 319,480,862 ordinary shares of £0.0025 each. The Company does not hold any ordinary shares in treasury. 

Therefore, as at 13 July 2011, the total number of voting rights in the Company is 319,480,862.

Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules ("DTR").

This announcement is in conformity with DTR 5.6.1.

- End -

DISCLAIMERS

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any State of the United States of America and the District of Columbia), Australia, Canada, South Africa or Japan. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, Ordinary Shares (the "Ordinary Shares") to any person in the United States of America, Australia, Canada, South Africa or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

The Ordinary Shares referred to herein have not been, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements of the US Securities Act of 1933 (the "US Securities Act"). The offer and sale of Ordinary Shares referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of Australia, Canada, South Africa or Japan. There will be no public offer of the Ordinary Shares in the United States of America, Australia, Canada, South Africa or Japan. Subject to certain exceptions, the Ordinary Shares referred to herein may not be offered or sold in Australia, Canada, South Africa or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, South Africa or Japan.

Any purchase or subscription of Ordinary Shares in the Global Offer should be made solely on the basis of the information contained in the final prospectus issued by the Company in connection with the Global Offer. No reliance may or should be placed by any person for any purposes whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness.

This announcement does not constitute a recommendation concerning the Global Offer. The value of Ordinary Shares can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the Global Offer for the person concerned. Past performance cannot be relied upon as a guide to future performance.

Credit Suisse Securities (Europe) Limited ("Credit Suisse"), J.P. Morgan Cazenove, RBC Capital Markets, Oriel Securities, Standard Bank and Lexicon Partners, each of which is authorised and regulated in the United Kingdom by the FSA, are acting exclusively for Ophir and no-one else in connection with the Global Offer. They will not regard any other person as their respective clients in relation to the Global Offer and will not be responsible to anyone other than Ophir for providing the protections afforded to their respective clients, nor for providing advice in relation to the Global Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

In connection with the Global Offer, Credit Suisse, J.P. Morgan Cazenove, RBC Capital Markets, Oriel Securities, Standard Bank and Lexicon Partners and any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase Ordinary Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Ordinary Shares and other securities of the Company or related investments in connection with the Global Offer or otherwise. Accordingly, references in the prospectus, once published, to the Ordinary Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Credit Suisse, J.P. Morgan Cazenove, RBC Capital Markets, Oriel Securities, Standard Bank and Lexicon Partners and any of their affiliates acting as investors for their own accounts. Credit Suisse, J.P. Morgan Cazenove, RBC Capital Markets, Oriel Securities, Standard Bank and Lexicon Partners do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

None of Credit Suisse, J.P. Morgan Cazenove, RBC Capital Markets, Oriel Securities, Standard Bank and Lexicon Partners or any of their respective directors, officers, employees, advisors or agents accepts any responsibility or liability whatsoever for/or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith.

In connection with the Global Offer, Credit Suisse, as Stabilisation Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares or effect other transactions with a view to supporting the market price of the Ordinary Shares at a higher level than that which might otherwise prevail in the open market. Credit Suisse is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings of the Ordinary Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. However, there will be no obligation on Credit Suisse or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilising measures, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Ordinary Shares above the offer price. Save as required by law or regulation, neither Credit Suisse nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Global Offer.

In connection with the Global Offer, Credit Suisse, as Stabilisation Manager, may, for stabilisation purposes, over-allot Ordinary Shares up to a maximum of 10 per cent of the total number of Ordinary Shares comprised in the Global Offer. For the purposes of allowing it to cover short positions resulting from any such over-allotments and/or from sales of Ordinary Shares effected by it during the stabilisation period, Credit Suisse will be granted an option (the "Over-allotment Option") pursuant to which Credit Suisse may acquire additional Ordinary Shares up to a maximum of 10 per cent of the total number of Ordinary Shares comprised in the Global Offer (the "Over-allotment Shares") at the offer price. The Over-allotment Option will be exercisable in whole or in part, upon notice by Credit Suisse, for 30 calendar days after the commencement of conditional trading of the Ordinary Shares on the London Stock Exchange. Any Over-allotment Shares sold by Credit Suisse will be sold on the same terms and conditions as the Ordinary Shares being sold or issued in the Global Offer and will form a single class for all purposes with the other Ordinary Shares. Save as required by law or regulation, neither Credit Suisse nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Global Offer.

Certain figures contained in this document, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this document may not conform exactly with the total figure given.

J.P. Morgan Cazenove is a marketing name used by J.P. Morgan Securities Ltd.

RBC Capital Markets is a marketing name used by Royal Bank of Canada Europe Limited.